Skip to main content
SINT
NASDAQ Life Sciences

SINTX Q3 Revenue Jumps Tenfold to $2.2M, Net Loss Halved

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.74
Mkt Cap
$11.528M
52W Low
$1.4
52W High
$4.46
52W Position info
24% above low
Off High info
61% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

SINT sits 24% above its 52-week low of $1.4.

Summary

SINTX confirmed the $2.2 million Q3 revenue it pre-announced on October 1, but the full filing adds the numbers that matter: gross profit of $1.4 million at a 62% margin versus 45% a year ago, and a net loss cut 55% to $1.6 million from $3.5 million. Operating expenses fell 13% to $3.0 million, so the revenue jump is dropping through to the bottom line rather than being eaten by spending. The company ended the quarter with $2.0 million in cash and then pulled in another $2.0 million from 941,423 Class B warrants exercised at $2.14, which eases near-term funding pressure but leaves a very thin balance sheet against a $6.6 million nine-month burn. Commercial traction is the story to track: initial sales of the FDA-cleared SiNAPTIC Foot & Ankle Osteotomy Wedge System have started, and large-animal studies on silicon nitride-treated wound care textiles are due in the first quarter of 2027.

At the time of this announcement, SINT was trading at $1.74 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $11.5M. The 52-week trading range was $1.40 to $4.46. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

SINT - Latest Insights

SINT
Nov 05, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.62
Real-time Price: $1.12 info
Change: -$0.500 (-31%) info
Market Cap: $8.314M info
SINT
Oct 09, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.11
Real-time Price: $1.12 info
Change: -$0.990 (-47%) info
Market Cap: $8.314M info
SINT
Oct 01, 2026, 9:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.30
Real-time Price: $1.12 info
Change: -$1.18 (-51%) info
Market Cap: $8.314M info
SINT
Oct 01, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.23
Real-time Price: $1.12 info
Change: -$1.11 (-50%) info
Market Cap: $8.314M info
SINT
Aug 13, 2026, 9:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.65
Real-time Price: $1.12 info
Change: -$0.530 (-32%) info
Market Cap: $8.314M info